lansoprazole has been researched along with Neoplasms in 5 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of human cancer has been seriously hampered for decades by resistance to chemotherapeutic drugs." | 2.79 | High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. ( Buglioni, S; Carocci, F; Fais, S; Fanciulli, M; Francesco, M; Spugnini, EP; Vincenzi, B, 2014) |
| "The treatment of human cancer has been seriously hampered for decades by resistance to chemotherapeutic drugs." | 2.76 | Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. ( Baldi, A; Betti, G; Buglioni, S; Carocci, F; Citro, G; de Bazzichini, GM; Fais, S; Menicagli, F; Pantaleo, I; Spugnini, EP, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Takeda, A | 1 |
| Takano, N | 1 |
| Kokuba, H | 1 |
| Hino, H | 1 |
| Moriya, S | 1 |
| Abe, A | 1 |
| Hiramoto, M | 1 |
| Tsukahara, K | 1 |
| Miyazawa, K | 1 |
| Spugnini, EP | 2 |
| Buglioni, S | 2 |
| Carocci, F | 2 |
| Francesco, M | 1 |
| Vincenzi, B | 1 |
| Fanciulli, M | 1 |
| Fais, S | 2 |
| Baldi, A | 1 |
| de Bazzichini, GM | 1 |
| Betti, G | 1 |
| Pantaleo, I | 1 |
| Menicagli, F | 1 |
| Citro, G | 1 |
1 review available for lansoprazole and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
2 trials available for lansoprazole and Neoplasms
| Article | Year |
|---|---|
High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
Topics: Administration, Metronomic; Animals; Cat Diseases; Cats; Cyclophosphamide; Dog Diseases; Dogs; Dose- | 2014 |
Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Antineoplastic Agents; Cats; Compassionate Use Tri | 2011 |
2 other studies available for lansoprazole and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization‑associated cell death.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy-Related Protein 5; Azithromycin; Cell Deat | 2020 |